TH

Tyrosine hydroxylase (TH) is the rate-limiting enzyme of catecholamine biosynthesis, converting L-tyrosine to L-DOPA and thereby setting the pace of dopamine synthesis in dopaminergic neurons (PMID:37638996). Its catalytic output depends on tetrahydrobiopterin (BH4) supplied by GTP cyclohydrolase I (GCH1); hereditary GCH1 deficiency lowers BH4 and secondarily reduces TH activity and dopamine synthesis, causing DOPA-responsive dystonia, while severe TH deficiency itself causes juvenile Parkinsonism, both treatable with L-DOPA (PMID:37638996). TH activity is dynamically regulated by upstream signaling: chronic manganese exposure suppresses TH activity through a PKCδ–PP2A axis acting on TH-Ser40 phosphorylation (PMID:21310168), whereas extracellular HMGB1 raises TH mRNA via RAGE–JNK signaling and partially rescues MPP+-induced TH loss (PMID:28887039). In the mesolimbic pathway, morphine and morphine withdrawal modulate TH mRNA, activity, and dopamine turnover, with Argonaute 2 implicated in translational repression of TH mRNA during withdrawal (PMID:23927484). Beyond its enzymatic role, TH expression marks defined neuronal populations, including apical cochlear type II afferents (PMID:29055051), and TH together with Brn4 synergistically drives maturation of dopaminergic neurons from neural stem cells toward a DAT-expressing phenotype (PMID:24769320).

1. 2010 Low

   Establishing reliable quantification of TH-positive neurons was needed before TH could serve as a robust marker of dopaminergic populations in lesion and disease models.

   Evidence Stereological counting comparing chromogenic vs. fluorescence detection and Nissl/DAPI/NeuN markers in mouse and rat ventral midbrain

   PMID:20637754

   Open questions at the time

   • Methodological study only; no functional consequence of TH localization tested
   • Does not address TH regulation or enzymatic mechanism
2. 2011 Medium

   Identified an upstream signaling axis that negatively regulates TH activity, explaining how an environmental neurotoxin suppresses dopamine synthesis.

   Evidence TH activity and TH-Ser40 phosphorylation assays with PKCδ inhibitor rottlerin and PP2A activity measurement in differentiated mesencephalic dopaminergic cells exposed to manganese

   PMID:21310168

   Open questions at the time

   • Direct PP2A-mediated dephosphorylation of TH not reconstituted
   • Single lab, in vitro cell system
   • In vivo relevance to manganese neurotoxicity not established here
3. 2013 Medium

   Linked opioid exposure to TH regulation at the translational level, distinguishing changes in enzyme activity from changes in neuron number.

   Evidence Western blot, qRT-PCR, TH activity assay and immunohistochemistry in rat VTA/NAc after acute morphine and precipitated withdrawal

   PMID:23927484

   Open questions at the time

   • Ago2-mediated translational repression of TH mRNA proposed but not fully reconstituted
   • Direct Ago2–TH mRNA interaction not demonstrated
4. 2014 Medium

   Showed that TH alone is insufficient to generate mature dopaminergic neurons, requiring a transcription-factor partner to complete maturation.

   Evidence Co-transfection of TH with Brn4 into neural stem cells, with immunofluorescence, flow cytometry and Western blot for DAT, GDNF, GFRα-1, and Ret

   PMID:24769320

   Open questions at the time

   • Mechanism by which Brn4 induces GDNF/Ret signaling not resolved
   • Functional integration and survival of derived neurons in vivo not tested
5. 2016 Medium

   Validated the TH-Cre mouse line as a genetic tool, confirming that hemizygous Cre insertion does not constitutively disrupt the dopaminergic system.

   Evidence Western blot, HPLC for dopamine/metabolites, radioligand binding/uptake, and behavioral testing in TH-Cre vs. wild-type mice

   PMID:27453291

   Open questions at the time

   • Negative-result validation; does not address TH enzymatic mechanism
   • Subtle or conditional phenotypes not excluded
6. 2017 Medium

   Identified a positive transcriptional regulator of TH, connecting an inflammatory/danger signal to dopamine-synthesis capacity.

   Evidence Recombinant HMGB1 and MPP+ treatment of SN4741 dopaminergic cells with RAGE and JNK inhibitors and qRT-PCR readout

   PMID:28887039

   Open questions at the time

   • Single cell line, single lab
   • Transcription factors downstream of JNK acting on the TH promoter not identified
   • In vivo relevance not established
7. 2017 Medium

   Defined TH as a selective marker of a specific peripheral neuronal subpopulation, extending its diagnostic utility beyond central dopaminergic neurons.

   Evidence Immunofluorescence double-labeling and confocal microscopy of whole-mount cochlea from CGRPα-EGFP mice

   PMID:29055051

   Open questions at the time

   • Functional role of TH in type II afferents not tested
   • Whether TH produces catecholamines in these cells not addressed
8. 2023 High

   Consolidated the biochemical and genetic basis of TH function, establishing the GCH1–BH4–TH pathway and its disease consequences.

   Evidence Biochemical characterization, human genetic studies, and enzyme activity measurements in patient tissues and cell lines (synthesizing review)

   PMID:37638996

   Open questions at the time

   • Structural basis of BH4-dependent catalysis not detailed in this corpus
   • Phosphorylation-dependent activity regulation not integrated with cofactor supply here

• How the multiple regulatory inputs on TH (PKCδ–PP2A phosphorylation, HMGB1–RAGE–JNK transcription, Ago2 translational control, and BH4 cofactor supply) are coordinated within a single dopaminergic neuron remains unresolved.
• No integrated model linking transcriptional, translational, and post-translational control of TH
• Cell-type-specific regulatory logic across central vs. peripheral TH+ populations not defined